Bone remodelling is a tightly-coordinated and lifelong process of replacing old damaged
bone with newly-synthesized healthy bone. In the bone remodelling cycle, bone resorption …

Background Synthetic dyes consumption, such as tartrazine, quinoline yellow, sunset
yellow, azorubine, ponceau 4 R, erythrosine, allura red, patent blue, indigo carmine, brilliant …

Tocotrienol has been shown to prevent bone loss in animal models of postmenopausal
osteoporosis, but the low oral bioavailability might limit its use. A self-emulsifying drug …

Postmenopausal women are susceptible to osteoporosis and osteoarthritis. Tocotrienol, a
bone-protective nutraceutical, is reported to prevent osteoarthritis in male rats. However, its …

Glucocorticoid-induced osteogenic dysfunction is the main pathologyical mechanism
underlying the development of glucocorticoid-induced osteoporosis. Glucocorticoids …

Menopause is the leading cause of osteoporosis for elderly women due to imbalanced bone
remodelling in the absence of oestrogen. The ability of tocotrienol in reversing established …

Purpose Natural antioxidants are considered as promising compounds in the
prevention/treatment of osteoporosis. We studied the ability of purified δ-tocotrienol (δ-TT) …

Purpose Annatto-derived tocotrienol (AnTT) has been shown to improve bone formation in
animal models of osteoporosis. However, detailed studies of the effects of AnTT on …

Male osteoporosis is a significant but undetermined healthcare problem. Men suffer from a
higher mortality rate post-fracture than women and they are marginalized in osteoporosis …

Bone remodeling and repair require osteogenic cells to reach the sites that need to be
rebuilt, indicating that stimulation of osteoblast migration could be a promising …